SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

SAN

77.39

+2.99%↑

ARGX

727.4

+2.16%↑

SHL.DE

+2.58%↑

PHIA

22.81

+3.26%↑

FRE

37.25

+1.92%↑

Home・Aktien・Gerresheimer AG

Gerresheimer AG

Open

BrancheGesundheitswesen

26.06 -1.06

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

25.34

Max

26.72

Schlüsselkennzahlen
By Trading Economics
Einkommen	-13M
Verkäufe	561M
KGV Branchendurchschnitt	39.824 49.888
Dividendenrendite	0.15
Gewinnspanne	-2.265
Angestellte	13,535
EBITDA	74M

Empfehlungen
By TipRanks
Empfehlungen	Sell
12-Monats-Prognose	-17.98% downside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	0.15% 2.38%
Nächstes Ergebnis	14. Juli 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	935M
Vorheriger Eröffnungskurs	27.12
Vorheriger Schlusskurs	26.06

Nachrichtenstimmung

By Acuity

38%

62%

110 / 344 Ranking in Healthcare

Gerresheimer AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Gerresheimer AG Prognose

Kursziel

By TipRanks

-17.98% Nachteil

12-Monats-Prognose

Durchschnitt 21.57 EUR -17.98%

Hoch 26.8 EUR

Tief 18.9 EUR

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Gerresheimer AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Sell

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Gerresheimer AG – Dist abgegeben haben.

Stimmung

By Acuity

110 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.